Ayass BioScience, LLC

Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. In the ever-evolving...

Genetic testing,pharmacogenetic testing,aptamer research and development,bioinformatics services,laboratory testing,next generation sequencing,covid-19 testing,and antibody testing

Ayass bioscience, llc operates in the Medical practices industry.

Ayass bioscience, llc's revenue is 11m - 100m

Ayass bioscience, llc has 11 - 50 employees.